Active Ingredient History
Fluconazole, a synthetic antifungal agent of the imidazole class, is used to treat vaginal candidiasis. It inhibits the fungal lanosterol 14 alpha-demethylase which thereby prevents the formation of ergosterol which is an essential component in the fungal cell membrane. Indicated for the treatment of fungal infections. NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Candidiasis, Vulvovaginal (approved 1990)
Meningitis, Cryptococcal (approved 1990)
Abdominal Injuries (Phase 2)
Acquired Immunodeficiency Syndrome (Phase 4)
AIDS-Related Opportunistic Infections (Phase 3)
Alzheimer Disease (Phase 1)
Antibiotic Prophylaxis (Phase 3)
Appendicitis (Phase 3)
Arrhythmias, Cardiac (Phase 3)
Arteries (Phase 4)
Aspergillosis (Phase 3)
Aspergillus (Phase 3)
Bacterial Infections (Phase 3)
Bacterial Infections and Mycoses (Phase 4)
Biological Availability (Phase 1)
Blastomycosis (Phase 2)
Burns (Phase 4)
Candidemia (Phase 3)
Candidiasis (Phase 4)
Candidiasis, Invasive (Phase 3)
Candidiasis, Oral (Phase 4)
Candidiasis, Vulvovaginal (Phase 4)
Cardiovascular Diseases (Phase 1)
Central Nervous System Fungal Infections (Phase 4)
Coccidioidomycosis (Phase 4)
Conjunctivitis (Phase 4)
Crohn Disease (Phase 2)
Cryptococcosis (Phase 4)
Cryptococcus (Phase 3)
Cryptococcus neoformans (Phase 4)
Dermatitis, Atopic (Phase 1)
Diabetes Mellitus (Phase 3)
Diabetes Mellitus, Type 2 (Phase 1)
Drug Interactions (Phase 1)
Duodenal Ulcer (Phase 3)
Endometriosis (Phase 1)
Fluconazole (Phase 4)
Fungemia (Phase 4)
Graft vs Host Disease (Phase 1)
Head and Neck Neoplasms (Phase 2/Phase 3)
Health (Phase 1)
Healthy Volunteers (Phase 4)
Heart Arrest (Phase 1)
Hematopoietic Stem Cell Transplantation (Phase 2)
Histoplasmosis (Phase 2)
HIV (Phase 3)
HIV Infections (Phase 4)
Hypercalciuria (Phase 3)
Hyperlipidemias (Phase 2)
Hypothermia (Phase 3)
Infant, Very Low Birth Weight (Phase 2)
Infections (Phase 3)
Intestinal Diseases (Phase 3)
Invasive Fungal Infections (Phase 4)
Leishmaniasis, Cutaneous (Phase 3)
Leukemia (Phase 3)
Leukemia, B-Cell (Phase 1)
Leukemia, Monocytic, Acute (Phase 3)
Leukemia, Myeloid (Phase 3)
Leukemia, Myeloid, Acute (Phase 3)
Leukemia, Myelomonocytic, Acute (Phase 3)
Leukopenia (Phase 3)
Liver Transplantation (Phase 3)
Lung Diseases, Fungal (Phase 4)
Lymphoma (Phase 3)
Lymphoma, B-Cell, Marginal Zone (Phase 1)
Lymphoma, Large B-Cell, Diffuse (Phase 1)
Lymphoma, Mantle-Cell (Phase 1)
Meningitis (Phase 2)
Meningitis, Cryptococcal (Phase 4)
Meningoencephalitis (Phase 2)
Metabolic Detoxication, Phase I (Phase 1)
Mycoses (Phase 4)
Mycosis Fungoides (Phase 3)
Neoplasms (Phase 3)
Nephrocalcinosis (Phase 3)
Nephrolithiasis (Phase 3)
Neutropenia (Phase 3)
Non-alcoholic Fatty Liver Disease (Phase 1)
Obesity (Phase 4)
Osteoarthritis, Knee (Phase 3)
Pain (Phase 1)
Pharmacology, Clinical (Phase 1)
Pneumocystis (Phase 3)
Pneumonia, Ventilator-Associated (Phase 3)
Prostatic Neoplasms (Phase 1)
Pulmonary Disease, Chronic Obstructive (Phase 1)
Respiratory Syncytial Virus Infections (Phase 1)
Sepsis (Phase 4)
Sexually Transmitted Diseases (Phase 3)
Sporotrichosis (Phase 2)
Stem Cell Transplantation (Phase 1)
Therapeutic Equivalency (Phase 1)
Tinea Capitis (Phase 3)
Tinea Versicolor (Phase 1)
Urinary Bladder, Overactive (Phase 1)
Vaginal Discharge (Phase 3)
Vaginitis (Phase 3)
Vaginosis, Bacterial (Phase 3)
Vulvovaginitis (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
